ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICARDO MARTINEZ

Internal Medicine

41,674

$706K

1810
1737 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $56

JOSE GARCIA

Internal Medicine

41,234

$837K

1287
1228 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $56

RUBEN AYALA MD

Internal Medicine

41,017

$3.13M

1083
898 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$76
Average prescription price

Avg: $56

MARIA BETANCOURT

Internal Medicine

40,070

$839K

1514
1447 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$21
Average prescription price

Avg: $56

ELADIO DIEGUEZ MD

Internal Medicine

39,045

$2.01M

1058
925 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

MOISES ISSA M.D.

Internal Medicine

38,568

$1.53M

2545
2124 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

KULMEET KUNDLAS M.D.

Internal Medicine

38,127

$1.33M

1819
1125 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

GLORIA CASAL

Internal Medicine

37,815

$679K

1358
1291 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$18
Average prescription price

Avg: $56

YOHANA CABRERA

Internal Medicine

37,742

$525K

1080
1020 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$14
Average prescription price

Avg: $56

MARIA FERNANDEZ

Internal Medicine

37,392

$554K

928
895 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$15
Average prescription price

Avg: $56

GIGLIOLA ARNEJO

Internal Medicine

36,680

$605K

1517
1424 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $56

CARLA FRIDMAN

Internal Medicine

36,279

$441K

1570
1472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

1%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$12
Average prescription price

Avg: $56

NICOLE GALLEGO MD

Internal Medicine

35,395

$576K

1253
1173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $56

GLORIA PIEDRA

Internal Medicine

35,174

$1.94M

730
634 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

AZZAM ADHAL MD

Internal Medicine

35,052

$2.18M

791
508 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $56

MIGUEL VAZQUEZ

Internal Medicine

35,035

$601K

1075
1037 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$17
Average prescription price

Avg: $56

JORGE VENEREO M.D.

Internal Medicine

34,625

$1.75M

775
717 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

TERESA ALFONSO M.D.

Internal Medicine

34,501

$1.71M

821
690 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

SON CHAU M.D.

Internal Medicine

34,243

$1.78M

963
782 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

RAMON CARRILLO M.D.

Internal Medicine

34,082

$1.73M

1216
1133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

1%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

CHANDRAVADAN PATEL MD

Internal Medicine

34,077

$1.19M

1087
804 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

RAVI GUPTA M.D.

Internal Medicine

33,574

$1.81M

1568
1287 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

MISBAH FAROOQI M.D.

Internal Medicine

33,208

$1.98M

673
465 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

LUIS GUTIERREZ M.D.

Internal Medicine

33,166

$1.24M

1066
980 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

DANIEL FORTIER M.D.

Internal Medicine

32,746

$2.28M

974
901 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank